Zobrazeno 1 - 10
of 108
pro vyhledávání: '"H, Charitansky"'
Autor:
C. Manivit, A. Dannepond, J.-L. Brun, V. Pinsolle, V. Casoli, H. Charitansky, J. Babin-Commeny
Publikováno v:
Gynécologie Obstétrique Fertilité & Sénologie. 50:650-656
Publikováno v:
Journal de Chirurgie Viscérale.
Autor:
Larry Blanchard, H. Charitansky, Richard Iggo, Isabelle Soubeyran, Laetitia Mayeur, Valérie Velasco, Gaëtan MacGrogan, Romain Boidot, Gaëlle Pérot, Claire Billerey-Larmonier, Emmanuel Khalifa, Julie Massé, Caroline Truntzer, Laurent Arnould
Publikováno v:
Modern Pathology. 33:1041-1055
Adenoid cystic carcinoma (ACC) of the breast with a predominant solid pattern is difficult to diagnose with certainty and differentiate from more common triple-negative breast cancers (TNBCs) of basal-phenotype. To better characterize solid ACC, we p
Autor:
C, Manivit, A, Dannepond, J-L, Brun, V, Pinsolle, V, Casoli, H, Charitansky, J, Babin-Commeny
Publikováno v:
Gynecologie, obstetrique, fertilitesenologie. 50(10)
Patients with very high risk of cancer mutation may decide to undergo prophylactic surgery in order to avoid heavy clinical and radiological monitoring. This is a promising and nonetheless risky surgery because it is a complicated procedure and highl
Autor:
Simone Mathoulin-Pélissier, H. Charitansky, Aurélien Rousvoal, M. Fournier, S. Croce, Christine Tunon de Lara, Margaux l'Henaff, Florence Chassaigne, Houda Ben Rejeb, Gaëtan MacGrogan, Vincent Pinsolles, Véronique Brouste, E. Bussieres
Publikováno v:
EJSO-European Journal of Surgical Oncology
EJSO-European Journal of Surgical Oncology, WB Saunders, 2019, 45, pp.950-955. ⟨10.1016/j.ejso.2019.01.014⟩
EJSO-European Journal of Surgical Oncology, WB Saunders, 2019, 45, pp.950-955. ⟨10.1016/j.ejso.2019.01.014⟩
Introduction Ductal carcinoma in situ (DCIS) accounts for 15% of all breast cancers and generally, the prognosis is good if treated optimally. The standard treatment includes breast conservative surgery along with adjuvant radiotherapy. Skin-sparing
Autor:
C. Tunon de Lara, Marc Debled, V Bubien, P. Lagarde, Michel Longy, M. Fournier, E Barrouk-Simonet, Simone Mathoulin-Pélissier, J Leroux, T Esnaud, F Chassaigne, C. Breton-Callu, Gaëtan MacGrogan, H. Charitansky, A. Petit, N Quenel-Tueux, Nicolas Sevenet, Françoise Bonnet
Publikováno v:
Cancer Research. 79:P5-09
Introduction Neoadjuvant chemotherapy (NAC) is proposed for locally advanced breast cancer (LABC) to increase the breast conservative treatment (BCT). In France, mastectomy is the risk-reducing prophylactic surgical strategy only for pre-symptomatic
Autor:
Anne Floquet, S. Cassauba, Camille Chakiba, Simone Mathoulin-Pélissier, N. Q. Tueux, Yann Godbert, T. Mottet, H. Charitansky, S. Enfedaque, Guilhem Roubaud, M. Fournier, Antoine Italiano, P. Soubeyran, L. Haik, Maud Toulmonde, C. Lebreton, M. Cabart, K. Bourcier, Simon Pernot, M. Annonay
Publikováno v:
Annals of Oncology. 32:S1150
Background: Although video teleconsultations (TCs) have shown benefits for clinical follow up in oncology, its development appears very delayed in routine practice. The COVID pandemic has required French physicians to use them, mostly during the firs
Autor:
Bastien Cabarrou, Florence Dalenc, Elodie Chantalat, Thomas Meresse, H. Charitansky, Camille Franchet, D. Gangloff, Charlotte Vaysse, Marc Soule-Tholy, Carole Massabeau, Benoit Chaput, Hugo Gornes, Eva Jouve
Publikováno v:
Clinical breast cancer. 19(4)
Background The treatment sequence involving a mastectomy and immediate breast reconstruction (IBR) via the latissimus dorsi flap technique after chemotherapy and radiotherapy is not common. Our experience of this alternative to the standard treatment
Autor:
C. Nos, S. Lasry, S. Giard, B. Flipo, J-M Classe, H. Charitansky, Anne-Sophie Bats, G. Le Bouedec, P. Bonnier, M.-C. Missana, Virginie Doridot, Charlotte Ngo, Krishna B. Clough, A. Charles-Nelson
Publikováno v:
European Journal of Surgical Oncology (EJSO). 42:1827-1833
Two thirds of node-positive breast cancer patients have limited pN1 disease and could benefit from a less extensive axillary lymph node dissection (ALND).172 breast cancers patients requiring an ALND were prospectively enrolled in the Sentibras Proto
Autor:
J.-R. Garbay, Richard Villet, Monique Cohen, Emile Daraï, Fabien Reyal, Pierre Azuar, S. Giard, J-M Classe, H. Charitansky, Eric Lambaudie, Pierre Gimbergues, Delphine Hudry, Gilles Houvenaeghel, Patrick Sfumato, C. Tunon de Lara, C. Faure, J.M. Boher, Roman Rouzier
Publikováno v:
European Journal of Cancer. 67:106-118
Background Omission of completion axillary lymph node dissection (ALND) is a standard practice in patients with breast cancer (BC) and negative sentinel nodes (SNs) but has shown insufficient evidence to be recommended in those with SN invasion. Meth